Prevacid

PrevOnco ™ incorporates lansoprazole, which is the generic anti-ulcer compound approved under the name Prevacid® and marketed in the U.S. by Takeda Pharmaceuticals North America,

BioSpace.com Featured News and Stories 2010

Another option might be the nonprescription version of Prevacid, called Prevacid 24HR, which recently hit store shelves earlier this month.

Hold the heartburn on Thanksgiving 2009

Another option might be the nonprescription version of Prevacid, called Prevacid 24HR, which recently hit store shelves earlier this month.

Hold the heartburn on Thanksgiving 2009

The increased risks appeared two years after patients started taking proton pump inhibitors such as Prevacid and histamine-2 receptor antagonists, or H2RAs, such as Zantac and Tagamet.

RushPRnews - Newswire & Global Press Release Distribution 2009

TOKYO—Takeda Pharmaceutical Co. said on Wednesday that its net profit fell 17% in the fiscal year that ended in March, hurt by the patent expiry of its key ulcer drug Prevacid and a firmer yen.

Takeda Profit Plunges 17% on Patent Expiry Kana Inagaki 2011

Associated Press Prevacid, a heartburn treatment made by Takeda Pharmaceuticals, travels the packaging line at a New Jersey facility shortly before it went over-the-counter in 2009.

Takeda in Talks to Acquire Nycomed Atsuko Fukase 2011

But access to Nycomed's oral respiratory drug Daxas is also critical for Takeda, with patents for Actos and its key stomach-ulcer drug Prevacid having expired in the U.S.

Takeda, Toshiba Make $16 Billion M&A Push Kana Inagaki 2011

More Japan Real Time: A Household Name in TV Ads For Takeda, growth in markets outside of Japan and a new pipeline is essential: Its key ulcer drug Prevacid has already expired in the U.S. and its best-selling Actos diabetes treatment expired in January.

Takeda in Talks to Acquire Nycomed Atsuko Fukase 2011

Sales of generic drugs in North America--the biggest market for such products--grew 48% from a year earlier to 5.76 billion rupees as the company benefited in the U.S. from a better market share for products like a version of Takeda Pharmaceutical Co.'s ulcer drug Prevacid and the launch of copies of drugs like Eisai Co.'s Aricept for treating Alzheimer's disease.

Dr. Reddy Profit Rises 25%, Misses Forecast Rumman Ahmed 2011

The presence of other limited-competition products like Takeda Pharmaceutical Co.'s ulcer drug Prevacid and AstraZeneca 's anti-asthma drug Accolate in its U.S. drug portfolio has also meant that the company has continued to enjoy good profits on their sales as there aren't too many competitors to push prices down.

Dr Reddy's Quarterly Profit Doubles Rumman Ahmed 2011